The clinical, social, and economic impacts of neurogenic lower urinary tract dysfunction (NLUTD) on individuals and health care systems are thought to be immense, yet the true costs of care are unknown. The aims of this study are to illuminate the global costs related to the current state of care for NLUTD.
A systematic review of the literature was performed using MEDLINE, the National Health Service Economic Evaluation Database, and the Cochrane Specialized Urology and Incontinence Registers. Studies reporting the health care costs of NLUTD were identified. All steps of the review were performed by 2 independent reviewers. Costs were converted to 2022 U.S. dollars and reported for different categories of services.
A total of 13 studies were included in the final review (12 from high-income economy, and 1 from an upper-middle-income economy). Routine maintenance care varied notably across studies in terms of included services. Annual supportive costs ranged from $2,039.69 to $12,219.07 with 1 study estimating lifetime costs of $112,774 when complications were considered. There were limited data on the costs of care from the patient's perspective. However, catheters and absorbent aids were estimated to be among the costliest categories of expenditure during routine care. More invasive and reconstructive treatments were associated with significant costs, ranging between $18,057 and $55,873.
NLUTD incurs a variety of health care expenditures ranging from incontinence supplies to hospitalizations for management of complications and leads to a significant burden for health care systems over the patient's lifetime. Approaches to NLUTD that focus on functional rehabilitation and restoration, rather than on management of complications, may prove to be a less costly and more effective alternative.
The Journal of urology. 2022 Jul 28 [Epub ahead of print]
Aidin Abedi, Aref S Sayegh, Nhi T Ha, Anibal La Riva, Laura C Perez, Priya Kohli, Armita Abedi, Rita P Jen, David A Ginsberg, Evgeniy Kreydin
Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California., University of Southern California, Institute of Urology, Keck School of Medicine, Los Angeles, California., School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran., University of Southern California Neurorestoration Center, Los Angeles, California.